Cargando…
Targeting DNA Damage Response as a Strategy to Treat HPV Infections
Mucosotropic human papillomaviruses (HPVs) cause prevalent anogenital infections, some of which can progress to cancers. It is imperative to identify efficacious drug candidates, as there are few therapeutic options. We have recapitulated a robust productive program of HPV-18 in organotypic raft cul...
Autores principales: | Banerjee, N. Sanjib, Moore, Dianne, Parker, Cameron J., Broker, Thomas R., Chow, Louise T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862220/ https://www.ncbi.nlm.nih.gov/pubmed/31683862 http://dx.doi.org/10.3390/ijms20215455 |
Ejemplares similares
-
PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro
por: Henken, Florianne E, et al.
Publicado: (2011) -
Strategies for targeting the DNA damage response for cancer therapeutics
por: Zhang, Dan, et al.
Publicado: (2012) -
The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021) -
Proteomics insights into DNA damage response and translating this knowledge to clinical strategies
por: von Stechow, Louise, et al.
Publicado: (2016) -
The DNA damage response activates HPV16 late gene expression at the level of RNA processing
por: Nilsson, Kersti, et al.
Publicado: (2018)